Product information and disease descriptionProduct descriptionProduct informationDrug/Drug, drug/disease interactions
Effects of Envudeucitinib on other drugs
3 evidence topics · 3 sources
Drug interaction potential stated by the manufacturer for combination therapy
Phase 1 interaction study with metformin and paroxetine: research ethics committee record
| Field | Quoted record |
|---|---|
| Study title | “Phase 1 Study on impact of ESK-001 PK on Metformin and Paroxetine in Healthy Participants” |
| IRAS ID | “1012125” |
| REC name | “North East - York Research Ethics Committee” |
| REC reference | “25/NE/0105” |
| Date of REC Opinion | “14 Jul 2025” |
| REC opinion | “Further Information Favourable Opinion” |
| Research summary | “Publication of this data is currently deferred.” |